UCSF World TB Day Symposium
The UCSF World TB Day Symposium took place on March 24, 2022. This event was co-hosted by the UCSF Center for ...
CurryTBCenter
What’s New—and Next—for TB Vaccines
Treatment Action Group and AVAC conducted a webinar featuring an update on recent vaccine results and possible next steps ...
HIVPxResearch
Ending the TB pandemic with innovative and updated WHO TB recommendations
The objectives of the course is to provide updates on the development, adaptation and implementation of the WHO evidence- ...
International Union Against Tuberculosis and Lung Disease
UCSF World TB Day Webinar
The UCSF World TB Day webinar took place on March 24, 2021. This event was co-hosted by the UCSF Center for Tuberculosis ...
CurryTBCenter
TB 2022 International Conference Focus on TB preventive therapy
TB 2022 International Conference On 24 March 2022 Topic: Focus on TB preventive therapy - Overall + Africa.
TB Thailand
Regulatory Best Practices for Global Access to Medicines Including Anti-TB Medicines Day 1-Session 1
CDER SBIA hosted a three, half-day conference in collaboration with the Promoting the Quality of Medicines Plus (PQM+) ...
U.S. Food and Drug Administration
June 2023 ACIP Meeting - Pneumococcal Vaccines
Introduction; Economic analysis and public health impact of PCV20 use in children; Comparison of cost-effectiveness analyses on ...
Centers for Disease Control and Prevention (CDC)
TB Elimination: Why Not Now? Session 2
A webinar series organized by The Union and ATS to discuss if the ambitious goals outlined in the WHO End TB Strategy and ...
American Thoracic Society
Regulatory Best Practices for Global Access to Medicines, Including Anti-TB Medicines - Day 1
This event is intended to help National Medicines Regulatory Authority's (NMRA) in low-and middle-income countries (LMICs) ...
U.S. Food and Drug Administration
TB 2022 International Conference | Focus on TB preventive therapy
TB 2022 International Conference On 24 March 2022 Topic: Focus on TB preventive therapy - Overall + Africa - Experience ...
EID CC Chulalongkorn
Webinar on What’s New in Childhood Tuberculosis?
Webinar on What's New in Childhood Tuberculosis? January 26th 2023.
Stop TB Partnership
Taking TB research literacy online (Community Connect)
Affected communities and advocates provide an important perspective for TB research and should be engaged throughout the ...
International Union Against Tuberculosis and Lung Disease
The TB Vaccine Advocacy Roadmap mobilizing a global advocacy response (Community Connect)
We need new, effective, safe, and accessible TB vaccines to end the TB epidemic. To make this a reality, the TB vaccine pipeline ...
International Union Against Tuberculosis and Lung Disease
Tuberculosis: International and Canadian perspectives on the “other” global pandemic
Tuberculosis (TB), one of the world's deadliest infectious killers, has a great deal in common with COVID-19. They're both ...
CADTH ACMTS
TB Elimination Why Not Now Session 1
A webinar series to discuss if the ambitious goals outlined in the WHO End TB Strategy and reinforced by the commitments made ...
American Thoracic Society
#WHA76 Strategic roundtable: Ending Tuberculosis by 2030
World Health Organization (WHO)
What’s New and Next for TB Vaccines and Recommendations To Control Spread of TB Infection
Medical Learning Hub welcomes you to a live webinar on “What's New and Next for TB Vaccines and Recommendations To ...
Medical Learning Hub
CDC’s Integral Role in Ending the Global TB Epidemic
Tuberculosis (TB) is the world's deadliest infectious disease, and its rate of decline in incidence is stalling. This must be met with a ...
CUGH TV
Emeritus Prof Robin Wood & Prof Linda-Gail Bekker – TB and COVID-19: Insights from South Africa
An online webinar where we heard from two of South Africa's most prominent infectious diseases researchers. Kirby Institute ...
Kirby Institute
Challenges to tuberculosis drug development
This webinar explores the current and future challenges, and potential solutions, to tuberculosis (TB) drug development and ...
National Institute for Health and Care Excellence (NICE)
Regulatory Best Practices for Global Access to Medicines, Including Anti-TB Medicines - Day 2
This event is intended to help National Medicines Regulatory Authority's (NMRA) in low-and middle-income countries (LMICs) ...
U.S. Food and Drug Administration
TB Seminar Brian Allwood 10 DEC 21
McGill TB Centre
Helen McShane: Challanges in TB vaccine development
Forskningskonferanser
Vaccines and Related Biological Products Advisory Committee – 4/6/2022
Join the U.S. Food and Drug Administration for an upcoming meeting of its Vaccines and Related Biological Products Advisory ...
U.S. Food and Drug Administration
August 2020 ACIP Meeting - Welcome & Introductions
Coronavirus Disease 2019 (COVID-19) Vaccines Introduction; mRNA-1273 Clinical Development; Pfizer/BioNTech COVID-19 ...
Centers for Disease Control and Prevention (CDC)
Swiss TPH Hybrid Symposium 2023: The Tuberculosis Pandemic – A Call to Action, Session 3.1
Session 3.1: From Science to Impact.
SwissTPH
Systematic screening for tuberculosis disease - Adapting and implementing global recommendations
Workshop: Systematic screening for tuberculosis disease - Adapting and implementing global recommendations to meet local ...
International Union Against Tuberculosis and Lung Disease
Pregnancy diagnosis l Dr umar khan
Vet Surgery
FoVI-TB 2022 // Session 07. International Virtual Forum on Tuberculosis (English channel)
FoVI-TB 2022 International Virtual Forum on Tuberculosis 2022 www.remitb.org Session 07 November 15, 2022 ⏰09:00 h Pacific ...
RemiTB
Swiss TPH Hybrid Symposium 2023: The Tuberculosis Pandemic – A Call to Action, Session 1.2
Session 1.2: Update on the TB Epidemic, Poverty and Politics.
SwissTPH
DOCTOR Vs. NURSE: Education #shorts
social Instagram: https://www.instagram.com/mikirai/ Kev's Insta: https://www.instagram.com/k3vmd/ TikTok: mikiraiofficial + ...
Miki Rai
Innovations For Tackling Tuberculosis In the Time of COVID 19
NASEM Health and Medicine Division
Regulatory Best Practices for Global Access to Medicines Including Anti-TB Medicines Day 1-Session 2
CDER SBIA hosted a three, half-day conference in collaboration with the Promoting the Quality of Medicines Plus (PQM+) ...
U.S. Food and Drug Administration
Man with vaccine side-effect has message for unvaccinated
Anthony Flint, who claims to have developed Guillain-Barré syndrome after his Johnson & Johnson Covid-19 vaccination, ...
CNN
What’s New for TB treatment?
Susan Swindells, MBBS Professor, Department of Internal Medicine, University of Nebraska Medical Centre; Medical Director, ...
HIV-NAT Thailand
Ending the TB Emergency - Plenary Session
This is a recording of the first plenary session of the 50th Union World Conference on Lung Health which took place in ...
International Union Against Tuberculosis and Lung Disease
Social Justice & The TB Epidemic. It is time to invest in human rights in TB.
Event organized by the Stop TB Partnership and with the Global Fund Communities Delegation and the O'Neill Institute for Global ...
Stop TB Partnership
Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected ...
Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts ...
IAC - the International AIDS Conference
Centre for International Child Health Seminar - 'Tuberculosis - why are we not winning the fight?'
The Centre for International Child Health launch their seminar series with the first event on tuberculosis on 16 March 2017.
Institute of Global Health Innovation
Session 2 - TB HIV 2019 Willem Hanekom
Current strategies and pipeline for novel TB vaccines.
IAS – the International AIDS Society
Community Led TB Accountability Priorities for the TB UN High Level Meeting in 2023
In 2020, over 150 TB affected communities and civil society partners contributed to the first global community TB accountability ...
International Union Against Tuberculosis and Lung Disease
Vaccines and Related Biological Products Advisory Committee – 6/28/2022
Join the U.S. Food and Drug Administration for an upcoming meeting of its Vaccines and Related Biological Products Advisory ...
U.S. Food and Drug Administration
